-
1
-
-
84929612515
-
Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders
-
Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev 2015; 26(3): 263–80.
-
(2015)
Cytokine Growth Factor Rev
, vol.26
, Issue.3
, pp. 263-280
-
-
Brisse, E.1
Wouters, C.H.2
Matthys, P.3
-
2
-
-
84877819974
-
Advances in understanding the pathogenesis of HLH
-
Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol 2013; 161(5): 609–622.
-
(2013)
Br J Haematol
, vol.161
, Issue.5
, pp. 609-622
-
-
Usmani, G.N.1
Woda, B.A.2
Newburger, P.E.3
-
3
-
-
84898663073
-
Hemophagocytic lymphohistiocytosis: pathogenesis and treatment
-
Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2013; 2013: 605–611.
-
(2013)
Hematology Am Soc Hematol Educ Program
, vol.2013
, pp. 605-611
-
-
Janka, G.E.1
Lehmberg, K.2
-
4
-
-
84907817138
-
Hereditary and acquired hemophagocytic lymphohistiocytosis
-
Zhang L, Zhou J, Sokol L. Hereditary and acquired hemophagocytic lymphohistiocytosis. Cancer Control 2014; 21(4): 301–312.
-
(2014)
Cancer Control
, vol.21
, Issue.4
, pp. 301-312
-
-
Zhang, L.1
Zhou, J.2
Sokol, L.3
-
5
-
-
84882782587
-
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
-
Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood 2013; 121(26): 5154–7.
-
(2013)
Blood
, vol.121
, Issue.26
, pp. 5154-5157
-
-
Teachey, D.T.1
Rheingold, S.R.2
Maude, S.L.3
-
6
-
-
78751681576
-
Successful treatment of severe paediatric rheumatic-disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
-
Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic-disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 2011; 50(2): 417–9.
-
(2011)
Rheumatology (Oxford)
, vol.50
, Issue.2
, pp. 417-419
-
-
Miettunen, P.M.1
Narendran, A.2
Jayanthan, A.3
Behrens, E.M.4
Cron, R.Q.5
-
7
-
-
84894448683
-
Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability
-
Ho C, Yao X, Tian L, Li FY, Podoltsev N, Xu ML. Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol 2014; 141(1): 62–71.
-
(2014)
Am J Clin Pathol
, vol.141
, Issue.1
, pp. 62-71
-
-
Ho, C.1
Yao, X.2
Tian, L.3
Li, F.Y.4
Podoltsev, N.5
Xu, M.L.6
-
8
-
-
33845619137
-
HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
-
Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48(2): 124–131.
-
(2007)
Pediatr Blood Cancer
, vol.48
, Issue.2
, pp. 124-131
-
-
Henter, J.I.1
Horne, A.2
Aricó, M.3
-
9
-
-
80055079785
-
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
-
Trottestam H, Horne A, Aricò M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011; 118(17): 4577–4584.
-
(2011)
Blood
, vol.118
, Issue.17
, pp. 4577-4584
-
-
Trottestam, H.1
Horne, A.2
Aricò, M.3
-
10
-
-
84923083822
-
Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis
-
Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 2015; 90(3): 220–224.
-
(2015)
Am J Hematol
, vol.90
, Issue.3
, pp. 220-224
-
-
Otrock, Z.K.1
Eby, C.S.2
-
11
-
-
84899943272
-
Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients
-
Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 2014; 93(2): 100–105.
-
(2014)
Medicine (Baltimore)
, vol.93
, Issue.2
, pp. 100-105
-
-
Li, J.1
Wang, Q.2
Zheng, W.3
-
12
-
-
84915731934
-
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide
-
Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 2015; 168(1): 63–68.
-
(2015)
Br J Haematol
, vol.168
, Issue.1
, pp. 63-68
-
-
Arca, M.1
Fardet, L.2
Galicier, L.3
-
13
-
-
84898886282
-
Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis
-
Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014; 89(4): 484–492.
-
(2014)
Mayo Clin Proc
, vol.89
, Issue.4
, pp. 484-492
-
-
Parikh, S.A.1
Kapoor, P.2
Letendre, L.3
Kumar, S.4
Wolanskyj, A.P.5
-
14
-
-
84955735455
-
Hemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years
-
Schram AM, Comstock P, Campo M, et al. Hemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br J Haematol 2016; 172(3): 412–9.
-
(2016)
Br J Haematol
, vol.172
, Issue.3
, pp. 412-419
-
-
Schram, A.M.1
Comstock, P.2
Campo, M.3
-
15
-
-
84907408074
-
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome
-
Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014; 66(9): 2613–2620.
-
(2014)
Arthritis Rheumatol
, vol.66
, Issue.9
, pp. 2613-2620
-
-
Fardet, L.1
Galicier, L.2
Lambotte, O.3
-
16
-
-
84960193018
-
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
-
Ravelli A, Minoia F, Davì S, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 2016; 75(3): 481–9.
-
(2016)
Ann Rheum Dis
, vol.75
, Issue.3
, pp. 481-489
-
-
Ravelli, A.1
Minoia, F.2
Davì, S.3
-
17
-
-
84895083284
-
Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China
-
Li F, Li P, Zhang R, et al. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med Oncol 2014; 31(4): 902.
-
(2014)
Med Oncol
, vol.31
, Issue.4
, pp. 902
-
-
Li, F.1
Li, P.2
Zhang, R.3
-
18
-
-
79953220496
-
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center
-
Machaczka M, Vaktnäs J, Klimkowska M, Hägglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma 2011; 52(4): 613–619.
-
(2011)
Leuk Lymphoma
, vol.52
, Issue.4
, pp. 613-619
-
-
Machaczka, M.1
Vaktnäs, J.2
Klimkowska, M.3
Hägglund, H.4
-
19
-
-
84885636323
-
Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution
-
Yu JT, Wang CY, Yang Y, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol 2013; 92(11): 1529–1536.
-
(2013)
Ann Hematol
, vol.92
, Issue.11
, pp. 1529-1536
-
-
Yu, J.T.1
Wang, C.Y.2
Yang, Y.3
-
20
-
-
46849090930
-
Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis
-
Shin HJ, Chung JS, Lee JJ, et al. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci 2008 Jun; 23(3): 439–444.
-
(2008)
J Korean Med Sci
, vol.23
, Issue.3
, pp. 439-444
-
-
Shin, H.J.1
Chung, J.S.2
Lee, J.J.3
-
21
-
-
84861685616
-
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
-
Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012 Jun; 13(4): 289–98.
-
(2012)
Genes Immun
, vol.13
, Issue.4
, pp. 289-298
-
-
Ravelli, A.1
Grom, A.A.2
Behrens, E.M.3
Cron, R.Q.4
-
22
-
-
84929512334
-
Clinical study of DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis
-
Wang Y, Huang W, Wei N, et al. Clinical study of DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Zhonghua Xue Ye Xue Za Zhi 2014; 35(10): 901–904.
-
(2014)
Zhonghua Xue Ye Xue Za Zhi
, vol.35
, Issue.10
, pp. 901-904
-
-
Wang, Y.1
Huang, W.2
Wei, N.3
-
23
-
-
84989297101
-
Alternative therapy for epstein-barr virus related hemophagocytic lymphohistiocytosis
-
Al Asad O, Salam A, Mannem S, Ninan M, Markowitz A, Jana B. Alternative therapy for epstein-barr virus related hemophagocytic lymphohistiocytosis. Case Rep Oncol Med 2015; 2015: 508387.
-
(2015)
Case Rep Oncol Med
, vol.2015
, pp. 508387
-
-
Al Asad, O.1
Salam, A.2
Mannem, S.3
Ninan, M.4
Markowitz, A.5
Jana, B.6
-
24
-
-
84880319443
-
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens
-
Chellapandian D, Das R, Zelley K, et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol 2013; 162(3): 376–382.
-
(2013)
Br J Haematol
, vol.162
, Issue.3
, pp. 376-382
-
-
Chellapandian, D.1
Das, R.2
Zelley, K.3
|